中文版 | English
题名

Vaccine-breakthrough infection by the SARS-CoV-2 omicron variant elicits broadly cross-reactive immune responses

作者
通讯作者Chen, Zhiwei
发表日期
2022
DOI
发表期刊
ISSN
2001-1326
卷号12期号:1
相关链接[来源记录]
收录类别
语种
英语
重要成果
ESI高被引
学校署名
通讯
资助项目
Hong Kong Research Grants Council Collaborative Research Fund["C7156-20GF","C1134-20GF","C5110-20GF"] ; Health and Medical Research Fund[19181012] ; Shenzhen Science and Technology Program["JSGG20200225151410198","JCYJ20210324131610027"] ; China National Program on Key Research Project["2020YFC0860600","2020YFA0707500","2020YFA0707504"] ; Hong Kong Theme-Based Research Scheme["T11-706/18-N","T11-709/21-N"]
WOS研究方向
Oncology ; Research & Experimental Medicine
WOS类目
Oncology ; Medicine, Research & Experimental
WOS记录号
WOS:000748298100028
出版者
来源库
Web of Science
引用统计
被引频次[WOS]:25
成果类型期刊论文
条目标识符http://sustech.caswiz.com/handle/2SGJ60CL/273828
专题南方科技大学第二附属医院
作者单位
1.Univ Hong Kong, Li Ka Shing Fac Med, AIDS Inst, Pokfulam, L5-45,21 Sassoon Rd, Hong Kong, Peoples R China
2.Univ Hong KongPokfulam, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong Special Adm Reg, L5-45,21 Sassoon Rd, Hong Kong, Peoples R China
3.Univ Hong Kong Pokfulam, State Key Lab Emerging Infect Dis, Hong Kong Special Adm Reg, Hong Kong, Peoples R China
4.Univ Hong Kong, Ctr Virol Vaccinol & Therapeut Ltd, Hong Kong Special Adm Reg, Hong Kong, Peoples R China
5.Univ Hong Kong, Shenzhen Hosp, Dept Clin Microbiol & Infect Control, Shenzhen, Guangdong, Peoples R China
6.Southern Univ Sci & Technol, Affiliated Hosp 2, Natl Clin Res Ctr Infect Dis, Shenzhen, Guangdong, Peoples R China
7.Southern Univ Sci & Technol, Peoples Hosp 3, Natl Clin Res Ctr Infect Dis, Shenzhen, Guangdong, Peoples R China
8.Princess Margaret Hosp, Dept Med & Geriatr, Hong Kong Special Adm Reg, Hong Kong, Peoples R China
9.Princess Margaret Hosp, Dept Pathol, Hong Kong Special Adm Reg, Hong Kong, Peoples R China
10.Hosp Author, Qual & Safety Div, Hong Kong Special Adm Reg, Hong Kong, Peoples R China
通讯作者单位南方科技大学第二附属医院
推荐引用方式
GB/T 7714
Zhou, Runhong,To, Kelvin Kai-Wang,Peng, Qiaoli,et al. Vaccine-breakthrough infection by the SARS-CoV-2 omicron variant elicits broadly cross-reactive immune responses[J]. Clinical and Translational Medicine,2022,12(1).
APA
Zhou, Runhong.,To, Kelvin Kai-Wang.,Peng, Qiaoli.,Chan, Jacky Man-Chun.,Huang, Haode.,...&Chen, Zhiwei.(2022).Vaccine-breakthrough infection by the SARS-CoV-2 omicron variant elicits broadly cross-reactive immune responses.Clinical and Translational Medicine,12(1).
MLA
Zhou, Runhong,et al."Vaccine-breakthrough infection by the SARS-CoV-2 omicron variant elicits broadly cross-reactive immune responses".Clinical and Translational Medicine 12.1(2022).
条目包含的文件
条目无相关文件。
个性服务
原文链接
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
导出为Excel格式
导出为Csv格式
Altmetrics Score
谷歌学术
谷歌学术中相似的文章
[Zhou, Runhong]的文章
[To, Kelvin Kai-Wang]的文章
[Peng, Qiaoli]的文章
百度学术
百度学术中相似的文章
[Zhou, Runhong]的文章
[To, Kelvin Kai-Wang]的文章
[Peng, Qiaoli]的文章
必应学术
必应学术中相似的文章
[Zhou, Runhong]的文章
[To, Kelvin Kai-Wang]的文章
[Peng, Qiaoli]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
[发表评论/异议/意见]
暂无评论

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。